Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study-Reference-Cited by-同舟云学术

Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study

Published:2014-03-27 Issue:3 Volume:81 Page:408-417
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Pivonello Rosario¹,Petersenn Stephan²,Newell-Price John³,Findling James W.⁴,Gu Feng⁵,Maldonado Mario⁶,Trovato Andrew⁶,Hughes Gareth⁷,Salgado Luiz R.⁸,Lacroix André⁹,Schopohl Jochen¹⁰,Biller Beverly M.K.¹¹,

Affiliation:

1. Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia; Università Federico II di Napoli; Naples Italy

2. ENDOC Center for Endocrine Tumors; Hamburg Germany

3. The Medical School; University of Sheffield; Sheffield UK

4. Division of Endocrinology, Metabolism, and Clinical Nutrition; Medical College of Wisconsin; Milwaukee WI USA

5. Department of Endocrinology; Key Laboratory of Endocrinology; Ministry of Health; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences; Beijing China

6. Clinical Development, Oncology Business Unit; Novartis Pharma AG; Basel Switzerland

7. Novartis Pharmaceuticals Corporation; East Hanover NJ USA

8. Division of General Internal Medicine; Hospital das Clínicas; University of São Paulo Medical School; São Paulo Brazil

9. Division of Endocrinology; Department of Medicine; Centre hospitalier de l'Université de Montréal; Montreal QC Canada

10. Medizinische Klinik IV; University of Munich; Munich Germany

11. Neuroendocrine Clinical Center; Massachusetts General Hospital; Boston MA USA

Funder

Novartis Pharma AG

Novartis Pharmaceuticals Corporation

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Reference33 articles.

1. Cushing's syndrome;Pivonello;Endocrinology and Metabolism Clinics of North America,2008

2. Cushing's syndrome;Newell-Price;The Lancet,2006

3. Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement;Biller;Journal of Clinical Endocrinology & Metabolism,2008

4. Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire;Webb;European Journal of Endocrinology,2008

5. Psychosomatic aspects of Cushing's disease;Sonino;Psychotherapy & Psychosomatics,1998

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical treatment of functional pituitary adenomas, trials and tribulations;Journal of Neuro-Oncology;2024-05-18

2. Adipose tissue in cortisol excess: What Cushing’s syndrome can teach us?;Biochemical Pharmacology;2024-05

3. An individualized approach to the management of Cushing disease;Nature Reviews Endocrinology;2023-08-03

4. Medical treatment of Cushing’s disease with concurrent diabetes mellitus;Frontiers in Endocrinology;2023-04-17

5. An evaluation of pharmacological options for Cushing’s disease: what are the state-of-the-art options?;Expert Opinion on Pharmacotherapy;2023-03-19